Advertisement

Quanterix Corp., a Cambridge-based company that makes an array system for molecular diagnostic tests, said it will move its systems to the next level through a partnership with automated analyzer system company Stratec Biomedical AG of Germany.

The two will co-develop and manufacture a fully automated instrument for Quanterix’s Single Molecule Array (SiMoA) technology for both the life sciences and in vitro diagnostics (IVD) markets. Quanterix said it expects to launch a life sciences instrument in 2013, followed by the commercialization of an IVD platform in 2014.

SOURCE

Advertisement
Advertisement